Page results
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
This step-by-step guide explains how you can give yourself an injection of bortezomib at home.
-
The UCLH children’s FGC/M clinic provides specialist care for children and adolescents who have undergone or are at risk of FGC/M.
-
A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.
-
This page aims to help you decide if a post-dates induction of labour is the right decision for you and your baby.
-
This page is aimed at providing guidance and recommendations for patients, carers or family members following a high dose examination or procedure performed in the Neuroradiology department at NHNN, which involved ionising radiation.
-
Information about activating your MyCare UCLH app.
-
UCLH has received excellent results in the 2023 National Adult Inpatient Survey this year, with patients rating their overall care 8.8 out of 10. This is an improvement on last year's score of 8.7 and once again makes us the best performing acute/combined trust in England.
-
A lung cancer patient at UCLH is the first to receive a novel cancer vaccine designed to prime the immune system to recognise and fight cancer cells.
-
This information is for patients who are doing a breath test at home. It includes the risks, and explains how to prepare, complete and return the test, as well as what to expect after the test.
File results
-
FOI/2023/0235 - Hip and knee arthroplasty litigation
-
FOI/2023/0237 - Software solution to manage patient e-consent for school vaccinations/ immunisations and waitlist validation
-
FOI/2023/0244 - IT systems for digital dictation, speech recognition, outsourced transcription, video consultation and health information systems
-
FOI/2023/0247 - Treatment guidelines for Idiopathic Pulmonary Fibrosis
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI/2023/0249 - Treatments for clotting disorders - Haemophilia B, Von Willebrand Disease
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0262 - Clinical trial participation
-
FOI/2023/0275 - Trust statistics on spiking